Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 5 | Genome Medicine

Fig. 5

From: A polygenic score for height identifies an unmeasured genetic predisposition among pediatric patients with idiopathic short stature

Fig. 5

The PGSheight improves model discrimination between children with ISS-NF and pathologic growth disorders. A Scatter plot showing the relationship between the PGSheight and receiving a diagnosis of ISS-NF in the cohort of children with either ISS-NF or pathologic growth disorders. Logistic regression, adjusting for 10 PCs, was used to generate predicted probabilities of ISS. The gold line denotes the baseline probability of being classified as having ISS-NF. B Forest plot comparing discrimination (AUC) between ISS-NF and pathologic growth disorders when using a model with only age, sex, and 10 PCs (black), with addition of the MPH (blue) and with addition of the PGSheight (purple). Additional sensitivity analyses examined subgroups of children: (1) meeting the clinical definition of short stature at the initial visit (height SDS ≤  − 2), (2) with a diagnosis of a primary growth disorder, and (3) with a diagnosis of a secondary growth disorder

Back to article page

Genome Medicine

ISSN: 1756-994X

Contact us